Protix raises €50 million to expand its footprint in the insect protein space
The €50 million ($57M) investment will be used for international expansion and R&D efforts.
Protix’ next growth phase is all about global site expansion, building new facilities, and increasing capacity.
CEO and founder Kees Aarts says: “We are very pleased to welcome such an impact-oriented group of investors supporting our mission to bring the food system back in balance with nature. Their support marks an exciting next step for 2022 after a memorable 2021, when we realized continued commercial success, completed an exciting successful breeding program, and strengthened our organization with new talent in key positions. Continued appetite from financial institutions and impact investors alike reinforces our stepwise approach of scaling our business. This is an important step towards further exponential grow.
Impact investors step into the growth plan of Protix; European Circular Bioeconomy Fund (ECBF), BNP Paribas, the Prince Albert II Foundation and The Good Investors. This new funding is also supported by existing shareholders Aqua-Spark, Rabo Investments, and Invest-NL.